Estimated read time 2 min read

South Korean pharma giant, Celltrion, initiates share cancellation to enhance value

South Korean pharmaceutical giant Celltrion Inc. has announced its decision to cancel approximately 1 percent of its outstanding shares, a move aimed at bolstering shareholder [more…]

Estimated read time 3 min read

South Korean companies face profitability crunch amid economic challenges

In the face of a challenging economic environment, South Korean companies experienced a decline in sales growth and a narrowing of profitability in the third [more…]

Estimated read time 2 min read

South Korean stocks face headwinds amid U.S. government shutdown concerns and Moody’s rating cut

South Korean stocks experienced a downward trend on Monday, fueled by growing concerns over a potential US government shutdown following a downgrade in Moody’s rating [more…]

Estimated read time 3 min read

Coupang shares slides overshadowing its record Q3 earnings and growing customer base

In a recent announcement, South Korean e-commerce giant Coupang has continued its impressive financial winning streak by revealing record third-quarter earnings. These outstanding results are [more…]

Estimated read time 3 min read

South Korean stocks surge as short selling ban takes effect

South Korean stocks experienced an unprecedented surge on Monday, with the benchmark Korea Composite Stock Price Index (KOSPI) soaring by 5.6 percent, marking its sharpest-ever [more…]